Miriam S Komaromy, MD
Medical Director, Grayken Center for Addiction
Call for assistance with the referral process
Featured on HealthCity
The low-threshold, transitional housing model aims to help people experiencing homelessness alongside addiction, mental health, and other concerns.
Low-barrier, temporary housing allows people with addiction to stabilize and prepare for transition into permanent housing.
Grayken Center for Addiction staff testified to the state on the need for safe consumption sites to address opioid overdose deaths.
BMC experts testified in support of eliminating the requirement to report abuse and neglect for babies born with neonatal opioid withdrawal syndrome.
Miriam Komaromy, director of BMC's Grayken Center for Addiction cautions that the new rules don't go far enough in addressing opioid overdose deaths.
BMC created a medical unit to provide homeless, COVID-positive patients who were not sick enough to need hospitalization a location to recuperate.
Miriam Komaromy, MD, medical director for the Grayken Center for Addiction at BMC, reacts to the news of increased access to a key medication for OUD.
Pioneering curriculum aims to strengthen inpatient nursing’s role in providing evidence-based care for patients with substance use disorder.
In record time, local and state collaboration stands up respite care for stable COVID-positive people without a safe place to quarantine.
Addiction expert Miriam Komaromy offers a frank look at the opioid epidemic and shares how efforts are underway to keep crucial care accessible.
Virtual sessions between primary care providers and specialty providers help reduce expensive emergency department and inpatient care utilization.
More About Me
Dr. Miriam Komaromy is a physician and Medical Director of Boston Medical Center’s Grayken Center for Addiction. She is board certified in Internal Medicine and Addiction Medicine. Komaromy’s work leading the Grayken Center is focused on enhancing all of BMC’s work on addiction, including clinical programs, education, research, and policy/advocacy, as well as elevating this work to influence the national dialog on addiction. Komaromy received her medical training at the University of California, San Francisco, and later served as a faculty member in the UCSF Department of Medicine. She was a Robert Wood Johnson Clinical Scholar at the UCSF/Stanford program, Prior to moving to Boston in 2019, she was Associate Director in the University of New Mexico’s ECHO Institute, developing and leading medical education programs that are focused on treatment of substance use disorders, for the past 13 years.
University of California, San Francisco, CA (1989)